A TRIzol-based method for high recovery of plasma sncRNAs approximately 30 to 60 nucleotides
Kristen Rodgers(Johns Hopkins University), Yuping Mei(Johns Hopkins Hospital), Shun Ishiyama(Johns Hopkins University), Alicia Hulbert(Johns Hopkins University), Malcolm V. Brock(Johns Hopkins University), Hamza Khan(Johns Hopkins University), Maria Shishikura(Johns Hopkins University)
Cited by 8
Related Papers
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|909
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer
|Cancer Discovery|2011|681
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
|Cancer Cell|2012|652
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
|Nature|2021|546
Alterations of immune response of non-small cell lung cancer with Azacytidine
|Oncotarget|2013|391